Peripheral nerve elongation trial

JRCT ID: jRCTs032180098

Registered date:28/01/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Peripheral nerve disorder
• Date of first enrollment: 17/07/2020
• Target sample size: 3
• Study type: Interventional
• Intervention(s): Neurorapphy

Outcome(s)

• Primary Outcome: Safety of the nerve lengthening method

Secondary Outcome

Nerve regeneration( MMT, Semmes-Weinstein monofilament test,Tinel sign)
Electromyography

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: <= 64age old
• Gender: Both

Include criteria

Patients who injured peripheral nerve defect of limbs
20 years old or more and less than 65 years old

Exclude criteria

The diabetic patient who is under medication
The patient who have peripheral nerve disorder
The patient who has a serious heart disorder
The patient who has a doubt or diagnostic neoplastic lesion within 5 years before agreement
The woman that during the pregnancy or the pregnancy is doubted
The patient who received other study drugs within current 1 month.
The patient who has not ability for agreement with own will.
The patient who has not ability for agreement by the reading and writeing
The patient who has been judged to be inappropriate as a subject by the doctor incharge

Related Information

• Primary Sponsor: Yamazaki Masashi
• Source(s) of Monetary Support: Japan society for the promotion of science